NY York Cancer Consortium Annual Developmental Therapeutics Symposium

This is the agenda for this Friday's New York Cancer Consortium Annual Developmental Therapeutics Symposium:

8:10-8:15 AM  Introductory Remarks

Joseph A. Sparano, MD

The Epigenome as a Therapeutic Target     

Session Chair: Ari Melnick, MD

8:15-8:45 AM   Epigenomics in Disease Pathogenesis

John Greally, MD

8:45 AM - 9:15 AM  Therapeutic Targeting of the Epigenome

Ari Melnick, MD

9:15 AM - 9:45 AM  Clinical Application of Epigenomic Therapy 

Guido Marcucci, MD

9:45 AM- 10:00 AM  Panel Discussion

10:00-10:15 AM  Coffee break

New Therapeutic Targets     

Session Chair: Franco Muggia, MD

 

10:15-10:45 AM   c-Met Inhibitors

Joseph P. Eder, MD

10: 45-11:15 AM   HSP and Aurora Kinase Inhibitors

Kapil Bhalla, MD

11:15 AM – 11:45 AM  Hot Stuff in the CTEP Pipeline

Jamie Zwiebel, MD

11:45 AM-12:00 PM Panel Discussion 

12:00 PM – 1:00 PM   Lunch and Overview of NYCC Portfolio

Clinical Trial Designs     

Session Chair: Joseph A. Sparano, MD

1:00–1:45 PM   Scott Walder Memorial Lecture

   The Phase II Trial: Resource or Relic?

James Doroshow, MD

1:45 - 2:30 PM   Adaptive Trials Designs: Past, Present, and Future

Donald A. Berry, PhD

2:30-2:45 PM    Panel Discussion

2:45-3:00 PM    Coffee break

Highlights of 2008 AACR Meeting     

Session Chair: John Leonard, MD

3:00-3:45 PM    Translational and Novel Therapeutics - Solid Tumors

Eric Rubin, MD

3:45-4:30 PM    Translational and Novel Therapeutics -Hematologic Malignancies

Janice Gabrilove, MD

4:30 – 4:45   Panel Discussion

Meeting Adjournment